Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to examine the clinical dose range of ASP1585 based on the
efficacy, safety, and feasibility of treatment in chronic kidney disease patients on
hemodialysis with hyperphosphatemia.